BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 35885858)

  • 1. [Use of a xenogeneic collagen matrix on extraction sockets: a new approach in ARONJ prevention (in german)].
    Kuster I; Valdec S; Rücker M; Bichsel D
    Swiss Dent J; 2020 Feb; 130(2):139-145. PubMed ID: 32031353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T
    Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries.
    Taguchi A; Shiraki M; Morrison A; Khan AA
    Osteoporos Sarcopenia; 2017 Jun; 3(2):64-74. PubMed ID: 30775507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study.
    Shimizu R; Sukegawa S; Sukegawa Y; Hasegawa K; Ono S; Nakamura T; Fujimura A; Fujisawa A; Nakano K; Takabatake K; Kawai H; Nagatsuka H; Furuki Y
    Healthcare (Basel); 2022 Jul; 10(7):. PubMed ID: 35885858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiresorptive agent-related osteonecrosis of the jaw risk in cancer patients before bone-modifying agent therapy: A retrospective study of 511 patients.
    Kanno C; Kojima M; Tezuka Y; Yaginuma S; Kanaya Y; Kaneko T
    Bone; 2023 Dec; 177():116892. PubMed ID: 37689127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study.
    Sakai Y; Shindo T; Sato S; Takahashi A; Kunishima Y; Kato R; Itoh N; Okada M; Tachiki H; Taguchi K; Takayanagi A; Hotta H; Horita H; Matsukawa M; Matsuki M; Nishiyama K; Miyazaki A; Hashimoto K; Tanaka T; Masumori N
    J Bone Miner Metab; 2021 Jul; 39(4):661-667. PubMed ID: 33704573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.
    Tohashi K; Nakabayashi M; Kodani I; Kidani K; Ryoke K
    Yonago Acta Med; 2016 Mar; 59(1):45-53. PubMed ID: 27046950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.
    Fujieda Y; Doi M; Asaka T; Ota M; Hisada R; Ohnishi N; Kono M; Kameda H; Nakazawa D; Kato M; Amengual O; Takahata M; Yasuda S; Kitagawa Y; Atsumi T
    J Bone Miner Metab; 2020 Jul; 38(4):581-588. PubMed ID: 32076874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents.
    Nakai Y; Kanaki T; Yamamoto A; Tanaka R; Yamamoto Y; Nagahara A; Nakayama M; Kakimoto KI; Ishibashi M; Nishimura K
    J Bone Miner Metab; 2021 Mar; 39(2):295-301. PubMed ID: 32886176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Factors in Endodontic Surgery Using an Endoscope: A 1 Year Retrospective Cohort Study.
    Sukegawa S; Shimizu R; Sukegawa Y; Hasegawa K; Ono S; Fujimura A; Yamamoto I; Nakano K; Takabatake K; Kawai H; Nagatsuka H; Furuki Y
    Materials (Basel); 2022 May; 15(9):. PubMed ID: 35591687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications.
    Badescu MC; Rezus E; Ciocoiu M; Badulescu OV; Butnariu LI; Popescu D; Bratoiu I; Rezus C
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw.
    Kuo PI; Lin TM; Chang YS; Hou TY; Hsu HC; Lin SH; Chen WS; Lin YC; Wang LH; Chang CC; Chen JH
    Sci Rep; 2021 Jan; 11(1):1612. PubMed ID: 33452297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer.
    Van Poznak CH; Unger JM; Darke AK; Moinpour C; Bagramian RA; Schubert MM; Hansen LK; Floyd JD; Dakhil SR; Lew DL; Wade JL; Fisch MJ; Henry NL; Hershman DL; Gralow J
    JAMA Oncol; 2021 Feb; 7(2):246-254. PubMed ID: 33331905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Drug Holiday Reduces the Frequency and Severity of Medication-Related Osteonecrosis of the Jaw in a Minipig Model.
    Otto S; Pautke C; Arens D; Poxleitner P; Eberli U; Nehrbass D; Zeiter S; Stoddart MJ
    J Bone Miner Res; 2020 Nov; 35(11):2179-2192. PubMed ID: 32568416
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.